Summit Trail Advisors’s Cytokinetics CYTK Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$223K	Buy	+6,755	New	+$223K	﹤0.01%	1028
2018 Q3	–	Sell	-1,770	Closed	-$15K	–	321
2018 Q2	$15K	Buy	+1,770	New	+$15K	0.01%	409
2018 Q1	–	Sell	-1,680	Closed	-$16K	–	729
2017 Q4	$16K	Buy	+1,680	New	+$16K	﹤0.01%	1095